Independence of granzyme B secretion and interferon-γ production during acute simian immunodeficiency virus infection

被引:12
作者
Calarota, SA
Otero, M
Robinson, TM
Dai, AL
Lewis, MG
Boyer, JD
Weiner, DB
机构
[1] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[2] Bioqual, Rockville, MD USA
关键词
D O I
10.1086/503364
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Quantification of interferon ( IFN)-gamma by enzyme-linked immunospot ( ELISPOT) assay is currently used as a surrogate measurement of cytotoxic T lymphocyte ( CTL) activity in nonhuman primates, particularly in simian immunodeficiency virus ( SIV) models. Given that noncytotoxic cells and natural killer cells can also release IFN-gamma, quantification of granzyme B ( GrB), a molecule secreted predominantly by activated CD8(+) T cells, may represent an additional surrogate measurement of CTL activity. Methods. We evaluated, by ELISPOT assay, GrB activity in response to 3 overlapping SIV Gag peptide pools in 18 rhesus macaques with acute SIVmac251 infection and analyzed its correlation with IFN-g ELISPOT responses and plasma viral load. Results. SIV Gag-specific GrB activity increased from 3.9- to 14.4-fold after infection, compared with that observed before infection. GrB secretion did not correlate directly with IFN-gamma production. Importantly, SIV Gag specific IFN-gamma production was negatively correlated with plasma viral load, whereas GrB activity was not. However, the peak of GrB activity coincided with the lowest plasma viral load detected after infection, whereas the magnitude of IFN-gamma production was 1.8-fold lower than the GrB response; these results illustrate that the responses differ. Conclusion. Our data support the concept that the GrB and IFN-gamma ELISPOT assays measure immune responses in different immune-cell populations with unique specificities.
引用
收藏
页码:1441 / 1450
页数:10
相关论文
共 38 条
[31]   The Granzyme B ELISPOT assay: An alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity [J].
Kimberly Shafer-Weaver ;
Thomas Sayers ;
Susan Strobl ;
Eric Derby ;
Tracy Ulderich ;
Michael Baseler ;
Anatoli Malyguine .
Journal of Translational Medicine, 1 (1)
[32]   Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay [J].
Shafer-Weaver K.A. ;
Sayers T. ;
Kuhns D.B. ;
Strobl S.L. ;
Burkett M.W. ;
Baseler M. ;
Malyguine A. .
Journal of Translational Medicine, 2 (1)
[33]   Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells [J].
Slifka, MK ;
Rodriguez, F ;
Whitton, JL .
NATURE, 1999, 401 (6748) :76-79
[34]  
Spaeny-Dekking EHA, 1998, J IMMUNOL, V160, P3610
[35]   Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction [J].
Suryanarayana, K ;
Wiltrout, TA ;
Vasquez, GM ;
Hirsch, VM ;
Lifson, JD .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (02) :183-189
[36]  
TRAPANI JA, 1994, J BIOL CHEM, V269, P18359
[37]   A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques [J].
Wee, EGT ;
Patel, S ;
McMichael, AJ ;
Hanke, T .
JOURNAL OF GENERAL VIROLOGY, 2002, 83 :75-80
[38]   Suppression of human immunodeficiency virus type 1 replication by CD8(+) cells: Evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms [J].
Yang, OO ;
Kalams, SA ;
Trocha, A ;
Cao, HY ;
Luster, A ;
Johnson, RP ;
Walker, BD .
JOURNAL OF VIROLOGY, 1997, 71 (04) :3120-3128